| Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis J Bolaños-Meade, M Hamadani, J Wu, MM Al Malki, MJ Martens, ... New England Journal of Medicine 388 (25), 2338-2348, 2023 | 136 | 2023 |
| Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study MA Kharfan‐Dabaja, MM Al Malki, U Deotare, RV Raj, N El‐Jurdi, ... British journal of haematology 179 (5), 781-789, 2017 | 79 | 2017 |
| Efficacy of adoptive immunotherapy with donor lymphocyte infusion in relapsed lymphoid malignancies N El-Jurdi, T Reljic, A Kumar, J Pidala, A Bazarbachi, B Djulbegovic, ... Immunotherapy 5 (5), 457-466, 2013 | 57 | 2013 |
| Post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil as the new standard for graft-versus-host disease (GVHD) prophylaxis in reduced intensity conditioning … SG Holtan, M Hamadani, J Wu, MM Al Malki, L Runaas, H Elmariah, ... Blood 140 (Supplement 2), LBA-4-LBA-4, 2022 | 50 | 2022 |
| Gastrointestinal microbiome and mycobiome changes during autologous transplantation for multiple myeloma: results of a prospective pilot study N El Jurdi, A Filali-Mouhim, I Salem, M Retuerto, NM Dambrosio, L Baer, ... Biology of Blood and Marrow Transplantation 25 (8), 1511-1519, 2019 | 42 | 2019 |
| Hematopoietic cell transplant–related toxicities and mortality in frail recipients M Pamukcuoglu, S Bhatia, DJ Weisdorf, TE DeFor, C Ustun, M Nayar, ... Biology of Blood and Marrow Transplantation 25 (12), 2454-2460, 2019 | 31 | 2019 |
| Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor SG Holtan, AL Hoeschen, Q Cao, M Arora, V Bachanova, CG Brunstein, ... Blood Advances 4 (7), 1284-1295, 2020 | 29 | 2020 |
| The mycobiome: impact on health and disease states N El-Jurdi, MA Ghannoum Microbiology spectrum 5 (3), 10.1128/microbiolspec. funk-0045-2016, 2017 | 29 | 2017 |
| Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis JE Maakaron, MJ Zhang, K Chen, S Abhyankar, VR Bhatt, S Chhabra, ... Bone marrow transplantation 57 (6), 911-917, 2022 | 24 | 2022 |
| Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas? MA Kharfan-Dabaja, N El-Jurdi, E Ayala, AS Kanate, BN Savani, ... Bone marrow transplantation 52 (11), 1487-1494, 2017 | 22 | 2017 |
| Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes N El Jurdi, A Rayes, ML MacMillan, SG Holtan, TE DeFor, J Witte, M Arora, ... Blood advances 5 (5), 1352-1359, 2021 | 19 | 2021 |
| Do cancer and cancer treatments accelerate aging? R Bhatia, S Holtan, NE Jurdi, A Prizment, A Blaes Current oncology reports 24 (11), 1401-1412, 2022 | 16 | 2022 |
| Reduced enterohepatic recirculation of mycophenolate and lower blood concentrations are associated with the stool bacterial microbiome after hematopoietic cell transplantation A Saqr, B Carlson, C Staley, A Rashidi, M Al-Kofahi, T Kaiser, S Holtan, ... Transplantation and Cellular Therapy 28 (7), 372. e1-372. e9, 2022 | 16 | 2022 |
| Association of CD34 cell dose with 5-year overall survival after peripheral blood allogeneic hematopoietic cell transplantation in adults with hematologic malignancies TD Gauntner, CG Brunstein, Q Cao, D Weisdorf, ED Warlick, N El Jurdi, ... Transplantation and Cellular Therapy 28 (2), 88-95, 2022 | 16 | 2022 |
| Low-dose azacitidine with DNMT1 level monitoring to treat post-transplantation acute myelogenous leukemia or myelodysplastic syndrome relapse M Ueda, N El-Jurdi, B Cooper, P Caimi, L Baer, M Kolk, L Brister, ... Biology of Blood and Marrow Transplantation 25 (6), 1122-1127, 2019 | 13 | 2019 |
| Allograft for myeloma: examining pieces of the jigsaw puzzle E Malek, N El-Jurdi, N Kröger, M de Lima Frontiers in oncology 7, 287, 2017 | 13 | 2017 |
| Prophylactic foscarnet for human herpesvirus 6: effect on hematopoietic engraftment after reduced-intensity conditioning umbilical cord blood transplantation N El Jurdi, J Rogosheske, T DeFor, N Bejanyan, M Arora, V Bachanova, ... Transplantation and cellular therapy 27 (1), 84. e1-84. e5, 2021 | 12 | 2021 |
| Use of potentially inappropriate medications in older allogeneic hematopoietic cell transplantation recipients D Bhargava, M Arora, TE DeFor, CG Brunstein, B Thyagarajan, N El Jurdi, ... Biology of Blood and Marrow Transplantation 26 (12), 2329-2334, 2020 | 12 | 2020 |
| Autologous hematopoietic cell transplantation for adult acute myeloid leukemia: An obsolete or resurfacing concept? HM Lazarus, N El Jurdi Best Practice & Research Clinical Haematology 30 (4), 327-332, 2017 | 11 | 2017 |
| Chimeric antigen receptor T cell therapy for cancer: clinical applications and practical considerations JE Maakaron, M Hu, N El Jurdi bmj 378, 2022 | 9 | 2022 |
